Literature DB >> 9080336

Hypocholesterolaemic effects of Terminalia arjuna tree bark.

A Ram1, P Lauria, R Gupta, P Kumar, V N Sharma.   

Abstract

Diet-induced hyperlipidaemic rabbits were given 50% ethanolic extract of Terminalia arjuna tree bark in doses of 100 mg/kg (Group B, n = 6) and 500 mg/kg (Group C, n = 6) and compared with controls (Group A). At 60 days of intervention in Groups A, B and C mean +/- S.E.M. total cholesterol was 574 +/- 61, 320 +/- 29 and 217 +/- 44 mg/dl, respectively (P < 0.01); LDL cholesterol was 493 +/- 57, 271 +/- 30 and 162 +/- 44 mg/dl (P < 0.01); HDL cholesterol was 59 +/- 7, 36 +/- 3 and 35 +/- 4 mg/dl (P = n.s.); triglyceride was 108 +/- 13, 67 +/- 6 and 101 +/- 26 mg/dl (P = n.s.); cholesterol/HDL ratio was 10.1 +/- 1.3, 9.2 +/- 1.1 and 6.1 +/- 1.0 (P = n.s.); and LDL/HDL ratio was 8.7 +/- 1.3, 7.8 +/- 1.1 and 4.5 +/- 1.0 (P < 0.01). The extract did not adversely affect biochemical tests of liver and renal function and haematological parameters.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9080336     DOI: 10.1016/s0378-8741(96)01493-6

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  12 in total

1.  Antidiabetic effect ofT. arjuna bark extract in alloxan induced diabetic rats.

Authors:  B Ragavan; S Krishnakumari
Journal:  Indian J Clin Biochem       Date:  2006-09

2.  Anti-Atherogenic Activity of Ethanolic Fraction of Terminalia arjuna Bark on Hypercholesterolemic Rabbits.

Authors:  Saravanan Subramaniam; Ramachandran Subramaniam; Suja Rajapandian; Subasini Uthrapathi; Victor Rajamanickam Gnanamanickam; Govinda Prasad Dubey
Journal:  Evid Based Complement Alternat Med       Date:  2011-03-20       Impact factor: 2.629

3.  Aloe barbadensis Mill. formulation restores lipid profile to normal in a letrozole-induced polycystic ovarian syndrome rat model.

Authors:  Bhavna N Desai; Radha H Maharjan; Laxmipriya P Nampoothiri
Journal:  Pharmacognosy Res       Date:  2012-04

4.  Aqueous extract of Terminalia arjuna prevents carbon tetrachloride induced hepatic and renal disorders.

Authors:  Prasenjit Manna; Mahua Sinha; Parames C Sil
Journal:  BMC Complement Altern Med       Date:  2006-09-30       Impact factor: 3.659

Review 5.  Revisiting Terminalia arjuna - An Ancient Cardiovascular Drug.

Authors:  Shridhar Dwivedi; Deepti Chopra
Journal:  J Tradit Complement Med       Date:  2014-10

Review 6.  Medicinal properties of Terminalia arjuna (Roxb.) Wight & Arn.: A review.

Authors:  Augustine Amalraj; Sreeraj Gopi
Journal:  J Tradit Complement Med       Date:  2016-03-20

7.  A compilation of bioactive compounds from Ayurveda.

Authors:  Ramar Perumal Samy; Peter Natesan Pushparaj; Ponnampalam Gopalakrishnakone
Journal:  Bioinformation       Date:  2008-11-02

8.  Evaluation of Hypolipidaemic Activity of Capparis decidua.

Authors:  Neelkamal Chahlia
Journal:  Int J Biomed Sci       Date:  2009-03

9.  Terminalia arjuna's antioxidant effect in isolated perfused kidney.

Authors:  C David Raj; M Mohamed Shabi; J Jipnomon; R Dhevi; K Gayathri; U Subashini; G Victor Rajamanickam
Journal:  Res Pharm Sci       Date:  2012-07

10.  Protective Effect of Aqueous Extract of Terminalia arjuna against Dehydrating Induced Oxidative Stress and Uremia in Male Rat.

Authors:  Koushik Das; Partha Pratim Chakraborty; Debidas Ghosh; Dilip Kumar Nandi
Journal:  Iran J Pharm Res       Date:  2010       Impact factor: 1.696

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.